Sphingosine-1 Phosphate (S1P) is an enzyme in humans that has been shown to be upregulated by viruses to help them replicate and spread infection. Our work shows that inhibitors of S1P can protect from infection with Influenza A and other clinically relevant viral infections.
Primary Application Area: Biotech, Pharma, Health
Technology Development Status: Concept
Technology Readiness Level: TRL 3
Vetted Programs/Awards: University of Missouri has been issued US Patent 9,687,487 covering this technology.
Organization Type: Academic/Gov Lab
Showcase Booth #: T63
Market Keywords: Anti-viral, Influenza, Viral